Literature DB >> 32842115

Psychometric Findings for the SCAR-Q Patient-Reported Outcome Measure Based on 731 Children and Adults with Surgical, Traumatic, and Burn Scars from Four Countries.

Natalia I Ziolkowski1, Andrea L Pusic1, Joel S Fish1, Lily R Mundy1, Richard Wong She1, Christopher R Forrest1, Scott Hollenbeck1, Cristian Arriagada1, Manual Calcagno1, David Greenhalgh1, Anne F Klassen1.   

Abstract

BACKGROUND: Each year, millions of individuals develop scars secondary to surgery, trauma, and/or burns. Scar-specific patient-reported outcome measures to evaluate outcomes are needed. To address the gap in available measures, the SCAR-Q was developed following international guidelines for patient-reported outcome measure development. This study field tested the SCAR-Q and examined its psychometric properties.
METHODS: Patients aged 8 years and older with a surgical, traumatic, and/or burn scar anywhere on their face or body were recruited between March of 2017 and April of 2018 at seven hospitals in four countries. Participants answered demographic and scar questions, the Fitzpatrick Skin Typing Questionnaire, the Patient and Observer Scar Assessment Scale (POSAS), and the SCAR-Q. Rasch measurement theory was used for the psychometric analysis. Cronbach's alpha, test-retest reliability, and concurrent validity were also examined.
RESULTS: Consent was obtained from 773 patients, and 731 completed the study. Participants were aged 8 to 88 years, and 354 had surgical, 184 had burn, and 199 had traumatic scars. Analysis led to refinement of the SCAR-Q Appearance, Symptoms, and Psychosocial Impact scales. Reliability was high, with person separation index values of 0.91, 0.81, and 0.79; Cronbach alpha values of 0.96, 0.91, and 0.95; and intraclass correlation coefficient values of 0.92, 0.94, and 0.88, respectively. As predicted, correlations between POSAS scores and the Appearance and Symptom scales were higher than those between POSAS and Psychosocial Impact scale scores.
CONCLUSIONS: With increasing scar revisions, a scar-specific patient-reported outcome measure is needed to measure outcomes that matter to patients from their perspective. The SCAR-Q represents a rigorously developed, internationally applicable patient-reported outcome measure that can be used to evaluate scars in research, clinical care, and quality improvement initiatives.

Entities:  

Mesh:

Year:  2020        PMID: 32842115     DOI: 10.1097/PRS.0000000000007078

Source DB:  PubMed          Journal:  Plast Reconstr Surg        ISSN: 0032-1052            Impact factor:   4.730


  5 in total

1.  Nipple-Sparing Mastectomy versus Skin-Sparing Mastectomy: Does Saving the Nipple Impact Short- and Long-Term Patient Satisfaction?

Authors:  Bridget N Kelly; Heather R Faulkner; Barbara L Smith; Jenna E Korotkin; Conor R Lanahan; Carson Brown; Michele A Gadd; Michelle C Specht; Kevin S Hughes; T Salewa Oseni; Amy S Colwell; Suzanne B Coopey
Journal:  Ann Surg Oncol       Date:  2021-09-08       Impact factor: 5.344

2.  A Systematic Review and Meta-Analysis of Extracorporeal Membrane Oxygenation in Patients with Burns.

Authors:  Yu-Jen Chiu; Yu-Chen Huang; Tai-Wei Chen; Yih-An King; Hsu Ma
Journal:  Plast Reconstr Surg       Date:  2022-04-15       Impact factor: 5.169

3.  Arabic Translation and Linguistic Validation of the SCAR-Q Scale Module.

Authors:  Omar Braizat; Nasrin Jafarian; Sequina Al-Saigel; Salma Jarrar
Journal:  Cureus       Date:  2021-12-16

4.  The impact of incisional negative pressure wound therapy on scar quality and patient-reported outcomes: A within-patient-controlled, randomised trial.

Authors:  Floyd W Timmermans; Sterre E Mokken; Jan-Maerten Smit; Mark-Bram Bouman; Timotheus C van de Grift; Margriet G Mullender; Esther Middelkoop
Journal:  Wound Repair Regen       Date:  2022-02-21       Impact factor: 3.401

5.  Predictors for Estimating Scars' Internalization in Victims with Post-Traumatic Scars versus Patients with Postsurgical Scars.

Authors:  Gabriel Mihai Mekeres; Florica Voiţă-Mekereş; Cristina Tudoran; Camelia Liana Buhaş; Mariana Tudoran; Mariana Racoviţă; Nuţu Cristian Voiţă; Nicolae Ovidiu Pop; Mihai Marian
Journal:  Healthcare (Basel)       Date:  2022-03-16
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.